AMLX smart money
Amylyx Pharmaceuticals, INC. (AMLX): 2 insider buys, 6 top funds holding it, 2 ETF changes in the public filings.
Insider buys, 12 months$152k
Insider buys
| Filed | Who | Role | Amount | Price |
|---|---|---|---|---|
| 2026-05-26 | Firestone Karen | Director | $51k | $13.51 |
| 2025-12-23 | Firestone Karen | Director | $101k | $12.45 |
Top 100 funds holding it
| # | Fund | Change | Weight | Value |
|---|---|---|---|---|
| 14 | First Light Asset Management, LLC | ADD +32% | 6.88% | $116M |
| 19 | Tcg Crossover Management, LLC | 5.13% | $182M | |
| 31 | Affinity Asset Advisors, LLC | ADD +203% | 0.51% | $9M |
| 50 | Siren, L.L.C. | ADD +68% | 1.71% | $72M |
| 86 | Adar1 Capital Management, LLC | TRIM -26% | 0.50% | $11M |
| 96 | Pfm Health Sciences, LP | ADD +97% | 0.88% | $8M |
ETF changes
| ETF | Change | Value | Report |
|---|---|---|---|
| State Street(R) Spdr(R) S&p(R) Pharmaceuticals ETF | ADD | +$2M | 2026-06-30 |
| Ishares U.S. Pharmaceuticals ETF | TRIM | −$200k | 2026-06-30 |